Aspirin (generic), Bayer, Alka-Seltzer News

Main Category: Cardiovascular / Cardiology Also Included In: Clinical Trials / Drug Trials AstraZeneca announced it has submitted a New Drug Application to the US Food and Drug Administration for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome .

Cath Haywood didn't know she was having a heart attack. When her arm began to ache, she put it down over-enthusiastic ball throwing her springer spaniel demanded at least 50 lobs during their hour-long walks.

Findings from the Phase III EINSTEIN-Extension study will be presented in the Late Breaking Abstract Session on December 8, 2009, at the 51st Annual Meeting of the American Society of Hematology in New Orleans, Louisiana.

Would you like to receive Club Dog Newsletters? X Close Window Please provide us with your email address in order to access this valuable pet content.

Antiviral medications can sometimes help lessen influenza symptoms, but require a prescription.

AstraZeneca today announced it has submitted a New Drug Application to the U.S. Food and Drug Administration for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome .

Only swine flu deaths lead to hysteria. Understanding risk According to death statistics tables available on the 'net, you are ten times more likely to die in a car accident this year than be killed by swine flu.

An aspirin a day: is it right for you? Some people may be able to take aspirin every day to lower heart attack or stroke risks.

After years of little progress, three new trials suggest that the latest generation of blood thinners may outperform the old standbys warfarin and clopidogrel .

A CT scan - a kind of super X-ray - provides a faster, cheaper way to diagnose a heart attack when someone goes to the emergency room with chest pains, a new study suggests.

Virginia Wade was quoted as saying the patch's effects were "astounding' A press advert for a pain relief patch endorsed by tennis champion Virginia Wade has been banned on the grounds it could be misleading.

Main Category: Headache / Migraine Also Included In: Stroke ; Heart Disease ; Cardiovascular / Cardiology Article Date: 17 Nov 2009 - 0:00 PST printer friendly view / write opinions rate article Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with ...

More than 26,000 Patients Enrolled in Global Trial Evaluating Investigational Antiplatelet Agent in the Long-Term Prevention of Cardiovascular Events Whitehouse Station, NJ, Nov.

On Sunday, November 15, 2009, Florida Atlantic University researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Associationa s Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of ...

Submitted by admin on 11/15/2009 @ 6:00 AM Companies mentioned in this article: American Heart Association Study highlights: -STEMI patients had fewer cardiac events with a new reversible oral anti-platelet drug compared to standard treatment with an irreversible agent.

Federal health regulators have found tiny particles of trash in drugs made by biotechnology firm Genzyme.

It's the end of the world as we know it, and I feel -- like I have a headache. You will too, after seeing '2012,' director Roland Emmerich's monstrously over-the-top end-of-the-world epic.

Thursday, November 12, 2009 When stroke survivors who are prescribed daily aspirin stop taking the drug, they may triple their risk of a having another stroke within days, research shows.

In the midst of re-evaluating its roster of creative agencies, pharma giant Bayer has begun a review of media-buying duties in several major markets across the globe, executives familiar with the matter said.

The popular blood-thinner Plavix prevents heart attacks and strokes in both women and men, but the benefits differ slightly by gender, U.S. researchers said on Monday.